About H Jules and Company
H Jules and Company is a Healthcare company based in Nagpur (India) founded in 1991. Global distributor of pharmaceutical APIs, excipients, and formulations for various applications. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. Its Indian entity H Jules & Company Ltd reported revenue of ₹36.88 Cr. H Jules and Company offers products and services including APIs, Excipients, Direct Compression Granules, and Targetcoat. Its focus areas include Pharmaceuticals, APIs and Excipients, Distribution and Manufacturing. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
H Jules and Company Limited, founded in 1991, started as a trader of Active Pharmaceutical Ingredients and Excipients, evolving into a global distributor focused on specialized dosage forms like tablets and capsules. They supply products for therapeutic categories including analgesics and antibiotics, serving clients in countries such as Algeria and China. Based in Nagpur, India, the company emphasizes quality and has expanded into manufacturing pharmaceutical-grade polymers, meeting diverse market needs through distribution and innovation.
- Headquarters Nagpur, India
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website hjules.in
- Legal Name H Jules & Company Ltd
- Date of Incorporation 21 Jun, 1991
- Jurisdiction Nagpur, Maharashtra, India
- Annual Revenue₹36.88 Cr
FY 2023 · +19% YoY
- Net Profit₹1.83 Cr
FY 2023 · 5% margin
- EBITDA₹2.54 Cr
FY 2023 · 7% margin
Associated legal entities of H Jules and Company
H Jules and Company operates through H Jules & Company Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| H Jules & Company Ltd CIN U24230MH1991PLC062174 | Active | 21 Jun 1991 | Nagpur, Maharashtra | ₹36.9 Cr | 5 | View details |
Products & Services of H Jules and Company
H Jules and Company offers a comprehensive portfolio of products and services, including APIs, Excipients, Direct Compression Granules, and Targetcoat.
Active ingredients for drugs in categories like analgesics and antibiotics.
Inactive substances used in formulations for oral solids and injections.
Granules for tablet production serving cosmetics and injection needs.
Pharmaceutical-grade polymer for controlled release formulations.
Board of directors of H Jules & Company Ltd (H Jules and Company)
H Jules & Company Ltd is the primary company behind H Jules and Company. The board of H Jules & Company Ltd currently have 5 directors; the longest-serving is Gajanan Laxmanrao Bangadkar, appointed in 2011. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gajanan Laxmanrao Bangadkar DIN 03592469 | Whole-time director | 15 Dec 2011 | 14 yrs 10 mo | H Jules & Company Ltd |
| Bhavana DIN 08608864 | Whole-time director | 13 Nov 2019 | 6 yrs 11 mo | H Jules & Company Ltd |
| Himanshuranjan Awadeshchandra Tiwari DIN 06448161 | Director | 01 Jun 2022 | 4 yrs 5 mo | H Jules & Company Ltd |
| Hussain Rafi DIN 10204708 | Whole-time director | 01 Jul 2023 | 3 yrs 4 mo | H Jules & Company Ltd |
| Naresh Janardan Gaikwad DIN 02185462 | Whole-time director | 01 Jul 2023 | 3 yrs 4 mo | H Jules & Company Ltd |
Financials of H Jules and Company
Figures of H Jules & Company Ltd, the primary company behind H Jules and Company, for FY 2023. Revenue was ₹36.88 Cr (+19% year on year). Net profit was ₹1.83 Cr (5% margin). EBITDA was ₹2.54 Cr (7% margin). Revenue has grown at a compounded annual rate of +13% over three years and +24% over five years.
- ₹36.88 CrRevenue · FY 2023 · +19% YoY
- ₹1.83 CrNet profit · 5% margin
- ₹2.54 CrEBITDA · 7% margin
- ₹1.52 CrPaid-up capital
- +13%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of H Jules & Company Ltd are on its company page.
Detailed financial statements for H Jules and Company
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to H Jules and Company
H Jules and Company has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of H Jules and Company
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about H Jules and Company
H Jules and Company was founded in 1991.
H Jules and Company is headquartered in Nagpur, India. It is registered at Nagpur, Maharashtra, India.
The primary company behind H Jules and Company, H Jules & Company Ltd, reported revenue of ₹36.88 Cr for FY 2023, up 19% year on year.
H Jules and Company Limited, founded in 1991, started as a trader of Active Pharmaceutical Ingredients and Excipients, evolving into a global distributor focused on specialized dosage forms like tablets and capsules. They supply products for therapeutic categories including analgesics and antibiotics, serving clients in countries such as Algeria and China. Based in Nagpur, India, the company emphasizes quality and has expanded into manufacturing pharmaceutical-grade polymers, meeting diverse market needs through distribution and innovation.
H Jules and Company's top competitors include Laurus Labs, Symbiotec and SeQuent.
H Jules and Company offers APIs, Excipients, Direct Compression Granules, and Targetcoat.
H Jules and Company operates through H Jules & Company Ltd.
The legal entities of H Jules and Company currently have 5 directors, including Hussain Rafi, Bhavana, Naresh Janardan Gaikwad and others.